Blood sampling, questionnaire and phone call

Preclinical

Blood sampling, questionnaire and phone call is one of 2 therapeutic programs targeting Chronic Migraine. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Chronic MigraineNot yet recruiting

Chronic MigrainePreclinical

Not yet recruiting

Competition

Competitive Landscape

2 competitors in Chronic Migraine

#DrugCompanyPhaseTrials

XEOMIN

MMerz Pharmaceuticals GmbH

Phase 3

1 2

Blood sampling, questionnaire and phone call

UUniversity Hospital, Clermont-Ferrand

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

PreclinicalNot yet recruiting

Chronic Migraine

NCT07067112

Clinical

Trials by Indication[1]

Chronic Migraine1 trial

Suppressive Functions of Regulatory T Cells in Migraine

Not yet recruiting·UUniversity Hospital, Clermont-Ferrand·Preclinical·NCT07067112·24 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Blood sampling, questionnaire and phone call. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Blood sampling, questionnaire and phone call. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — University Hospital, Clermont-Ferrand company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: UUniversity Hospital, Clermont-Ferrand

Blood sampling, questionnaire and phone call

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Chronic Migraine1 trial

References

Drug Info

Quick Facts

Related News